GlassScriptPhysician profile
Kathryn Bell
NPI 1861162422
$5,856.18
in general payments reported to CMS, 2019-2025
39 companies · $5,404 in 2025
The $5,404 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.39 · 2024: $437 · 2025: $5,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,847 · Travel and Lodging: $735 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,847.23 |
| Travel and Lodging | $735.13 |
| Education | $258.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,030.82 | 2025 | Inspire |
| Neurelis, INC. | $669.20 | 2024-2025 | Valtoco |
| Ucb, INC. | $403.41 | 2024-2025 | Fintepla, Briviact, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $390.51 | 2025 | Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $380.63 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $337.78 | 2024-2025 | |
| Sk Life Science, INC. | $323.32 | 2024-2025 | |
| Abbvie INC. | $311.31 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $228.06 | 2025 | Daybue, Nuplazid |
| Pfizer INC. | $208.11 | 2024-2025 | |
| Lilly USA, LLC | $207.01 | 2025 | Kisunla, Amyvid, Zepbound |
| Alexion Pharmaceuticals, INC. | $151.86 | 2025 | Ultomiris |
| Axsome Therapeutics, INC. | $136.39 | 2025 | Symbravo, Sunosi |
| Vanda Pharmaceuticals INC. | $113.34 | 2025 | Ponvory |
| Eisai INC. | $111.44 | 2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.